Search research articles
Contact Us
Filters
Showing results (21-30 of 246) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Progression-free survival: helpful biomarker or clinically meaningless end point?
Alan P Venook, Josep Tabernero
JCO Oncology Practice
|
December 3, 2024
Reply to: "Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy," "Large-Scale DPD Testing Should Be More Than an Option," and "A Big Problem With a Feasible Solution, Not a Small Problem With a Complex Solution"
Bani Tamraz, Alan P Venook
JCO Oncology Practice
|
May 14, 2024
<i>DPYD</i> Pharmacogenetics: To Opt-in or to Opt-out
Bani Tamraz, Alan P Venook
Onkologie
|
September 25, 2007
An alternative therapy for patients with hepatic impairment?
Su-Pin Choo, Alan P Venook
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?
Alan P Venook, Leonard B Saltz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Novel therapeutics in hepatocellular carcinoma: how can we make progress?
Robin K Kelley, Alan P Venook
Oncology (Williston Park, N.Y.)
|
October 19, 2013
Biomarkers in colon cancer: the chasm between expectations and reality
Katherine Van Loon, Alan P Venook
Journal of Oncology Practice
|
December 13, 2016
Role of Biologics in Colon Cancer: Still Not Clear
Chloe E Atreya, Alan P Venook
The Oncologist
|
January 1, 2008
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy
Bert H O'Neil, Alan P Venook
Clinical Colorectal Cancer
|
August 23, 2011
Lactic acidosis and colon cancer: oncologic emergency?
Anne M Espinoza, Alan P Venook
Page
of 25
Search research articles
Search
Showing results (21-30 of 246) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 5, 2014
Progression-free survival: helpful biomarker or clinically meaningless end point?
Alan P Venook, Josep Tabernero
JCO Oncology Practice
|
December 3, 2024
Reply to: "Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy," "Large-Scale DPD Testing Should Be More Than an Option," and "A Big Problem With a Feasible Solution, Not a Small Problem With a Complex Solution"
Bani Tamraz, Alan P Venook
JCO Oncology Practice
|
May 14, 2024
<i>DPYD</i> Pharmacogenetics: To Opt-in or to Opt-out
Bani Tamraz, Alan P Venook
Onkologie
|
September 25, 2007
An alternative therapy for patients with hepatic impairment?
Su-Pin Choo, Alan P Venook
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Biologic agents in the treatment of colorectal cancer: the last decade; the lost decade?
Alan P Venook, Leonard B Saltz
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 30, 2013
Novel therapeutics in hepatocellular carcinoma: how can we make progress?
Robin K Kelley, Alan P Venook
Oncology (Williston Park, N.Y.)
|
October 19, 2013
Biomarkers in colon cancer: the chasm between expectations and reality
Katherine Van Loon, Alan P Venook
Journal of Oncology Practice
|
December 13, 2016
Role of Biologics in Colon Cancer: Still Not Clear
Chloe E Atreya, Alan P Venook
The Oncologist
|
January 1, 2008
Hepatocellular carcinoma: the role of the North American GI Steering Committee Hepatobiliary Task Force and the advent of effective drug therapy
Bert H O'Neil, Alan P Venook
Clinical Colorectal Cancer
|
August 23, 2011
Lactic acidosis and colon cancer: oncologic emergency?
Anne M Espinoza, Alan P Venook
Page
of 25